SCML4 Inhibitors
Chemical inhibitors of SCML4 work by disrupting its interactions with chromatin, its enzyme function, and its participation in cellular pathways. Okadaic Acid, by specifically inhibiting protein phosphatases PP1 and PP2A, maintains SCML4 in a phosphorylated state. This modification affects SCML4's ability to regulate chromatin-modifying complexes, as the phosphorylation status often dictates the protein's interaction with other cellular components. Histone deacetylase inhibitors (HDACis) such as Vorinostat, Trichostatin A, Entinostat, and Mocetinostat alter the acetylation pattern of histones. The modification of the acetylation landscape disrupts the way SCML4 interacts with chromatin, which is crucial for its role in modulating the structure and accessibility of chromatin to other factors involved in gene expression regulation.
Other inhibitors target more indirect pathways that can affect SCML4's function. 5-Azacytidine inhibits DNA methyltransferases, leading to hypomethylation of DNA and subsequent alterations in chromatin structure that can prevent SCML4 from binding to its targets. MG132 inhibits the proteasome, leading to an accumulation of ubiquitinated proteins, which could sequester interacting partners of SCML4 or disrupt its function in ubiquitin-mediated pathways. Autophagy inhibitors like Chloroquine and Bafilomycin A1 prevent the normal turnover of cellular components, which could involve proteins or organelles critical for SCML4's function. Finally, DNA damage response inhibitors like Olaparib, Mitoxantrone, and Camptothecin interfere with the recruitment and function of chromatin-associated proteins like SCML4 to sites of DNA damage, thereby impacting its role in the DNA repair processes. These chemical inhibitors collectively target multiple aspects of SCML4's function within the cell, from direct enzymatic activity to its broader role in chromatin modification and interaction with DNA repair mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a specific inhibitor of protein phosphatases PP1 and PP2A, which are responsible for the dephosphorylation of many serine/threonine phosphorylated proteins. Inhibition of these phosphatases by Okadaic Acid would maintain SCML4 in a hyperphosphorylated state, thus inhibiting its function as a regulator of chromatin-modifying complexes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat is a histone deacetylase inhibitor (HDACi). It alters the acetylation state of histones, which can disrupt the interaction of chromatin-associated proteins such as SCML4 with chromatin, consequently inhibiting SCML4's ability to modulate chromatin structure and function. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor. By decreasing DNA methylation, it can alter chromatin structure and function, which may inhibit the binding of SCML4 to its chromatin targets, impeding its role in chromatin remodeling. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, another histone deacetylase inhibitor, increases acetylation of histones, potentially disrupting the recruitment of SCML4 to chromatin, thereby inhibiting its functionality as a chromatin regulator. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can lead to an increased level of ubiquitinated proteins, potentially sequestering ubiquitin ligases or other proteins that interact with SCML4, thus inhibiting SCML4's role in ubiquitin-mediated pathways. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is known to inhibit lysosomal activity and autophagy. By inhibiting autophagy, it could prevent the turnover of proteins and organelles that SCML4 may interact with, thereby inhibiting SCML4's function in these processes. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits V-ATPases, which may lead to disruption of endosomal-lysosomal acidification affecting the turnover or localization of proteins that SCML4 requires for its function, thus indirectly inhibiting SCML4. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat is an HDAC inhibitor which may disrupt the epigenetic regulation of gene expression and impede SCML4 function by altering the chromatin landscape where SCML4 exerts its effects. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib is a PARP inhibitor which interferes with DNA repair mechanisms. By inhibiting PARP, it could affect the recruitment of chromatin-associated proteins like SCML4 to sites of DNA damage, indirectly inhibiting SCML4's DNA repair-associated functions. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone intercalates into DNA and inhibits topoisomerase II, leading to DNA damage and potentially affecting the recruitment and function of DNA damage response proteins such as SCML4. | ||||||